Lessons from niche-specific fitness of Staphylococcus aureus at the wound edge

Staphylococcus aureus persists in chronic diabetic wounds by adapting to their unique microenvironmental niche. Reconceptualizing pathogenesis as niche-specific ecological process highlights the need for therapies targeting wound-specific vulnerabilities and interspecies dynamics while leveraging immune components to disrupt pathogen–host adaptation.

Chronic diabetic wounds create unique microenvironments that Staphylococcus aureus’s survival and adaptability, underscoring the need to study bacterial fitness and develop wound-targeted therapies to disrupt its persistence.

Staphylococcus aureus is a paradox in plain sight. It’s a microorganism that lives with us, and against us¹. Roughly one in three people harbors them, never realizing they are hosting one of the most formidable pathogens of our time². This dual identity, as a commensal organism and an opportunistic pathogen, captures the delicate balance of host–microbe coexistence³. However, its transitions to virulence is devastating causing illness across a wide and deadly clinical spectrum¹. The persistence underscores not only the limitations of antibiotic therapy but also the extraordinary adaptability of this pathogen.

Traditional explanations of adhesins, toxins, biofilm formation, and immune evasion tell only part of S. aureus tale^1,3,4, accounting only for its inventory of arsenal, but not its strategy. What truly sets S. aureus apart is its remarkable fitness, the ability to decipher microenvironmental cues, recalibrate its physiology, and exploit host niches^3,5. This adaptability explains why the same strain remains benign in one host, yet causes a catastrophe in another. The central question is no longer why S. aureus is so virulent, but how it persist and thrive so successfully within the host despite formidable immune defenses? Until we understand how S. aureus seamlessly navigates the shifting line between colonization and invasion, we will continue to chase its shadows with antibiotics and electroceuticals^6,7, never quite touching the heart of its evolutionary triumph.

The recent study by Chang et al. disrupts a long-standing paradigm in our understanding of S. aureus pathogenesis⁸. They argue convincingly that its pathogenic potential cannot be reduced to a static catalog of virulence factors. Instead, its pathogenicity is a dynamic, niche-specific choreography that constantly recalibrates in response to the host microenvironment. By deploying transposon sequencing (Tn-seq) and rigorous mutant validation, they mapped the genetic architecture of S. aureus survival across three distinct niches: intracellular, extracellular (bloodstream), and systemic organ⁸. Their findings are both illuminating and thought-provoking. They identified 27 essential core genes encoding fundamental processes such as ATP synthesis, nucleotide metabolism, and ion transport that can also serve as an enticing target set for antimicrobial innovation. However, the more provocative insight lies in the fluidity of its context-dependent requirements. In blood, S. aureus thrives by exhibiting metabolic plasticity, metabolizing glucose and lactate while resisting oxidative assault. Within host cells, survival hinges on envelope-stress resistance, nutrient and metal acquisition, and time-dependent shifts in fitness requirements. In murine systemic infection, persistence demands tissue-specific strategies, such as the reinforcement of the tricarboxylic acid cycle (TCA) metabolites, purine biosynthesis, and ion homeostasis, each reflecting the immunometabolic heterogeneity of host organs. From this work, it is clear that S. aureus is an exemplary of adaptive versatility. This reframing compels us to question whether current therapies are misdirected by overemphasizing classical virulence determinants while ignoring the metabolic and environmental adaptability that sustains infection. Can targeting universal fitness genes succeed where anti-virulence approaches have failed? Most importantly, how do we reconceptualize bacterial pathogenicity as a dynamic systems-level phenomenon shaped by the host-pathogen dialog? The work of Chang et al. challenges us to move beyond the simplicity of “virulence factors” and confront the complexity of adaptive fitness⁸. In doing so, they force a paradigm shift that may redefine both the way we study S. aureus and how we attempt to disarm it. The adaptive plasticity of S. aureus by which it rapidly reprograms gene expression in response to host microenvironmental cues, means that each host is not just a backdrop, but an unique ecological niche, sculpted by comorbidities, immune responses, epigenetic modifications, and metabolic states^3,5.

Wounds as strategic battlegrounds and hidden bacterial reservoirs

Although skin and soft-tissue infections remain the clinical face of MRSA, non-healing chronic diabetic wounds also represent a distinct microenvironmental niche⁹. Unlike the acute systemic chaos of sepsis or pneumonia, wounds unfold at a very slow pace. Chronic wounds are metabolically deranged and constantly open to polymicrobial colonization by Pseudomonas, Enterococcus, anaerobes, and fungi^9–14. For S. aureus, this is an evolutionary playground. It transitions seamlessly between extracellular biofilms, intracellular refuges, and deep-tissue reservoirs, exploiting the disordered microenvironments that chronic wounds provide^1,15.

Previous studies have demonstrated that co-infection with Pseudomonas aeruginosa alters S. aureus gene expression. For example atpD gene was essential only under mono-infection conditions, underscoring the limitations of single-species models in capturing wound complexity¹⁶. It remains unclear whether wound-derived isolates share similar genetic dependencies or have evolved distinct strategies to adapt to the hypoxic, inflammatory, and polymicrobial environment of chronic wounds. And if so, can we consider therapies that selectively target and eliminate intracellular reservoirs without causing collateral damage to the host’s repair mechanisms?

Chang et al. and other demonstrated that, S. aureus does not rely on a single survival script but rewires itself depending on the tissue, cell type, or microbial community it encounters^16,17. Interestingly, chronic wounds embody all simultaneously. Exudate mirrors the nutrient and stress conditions of plasma; keratinocytes and fibroblasts become intracellular sanctuaries; and ischemic tissue imposes the metabolic constraints of organ niches. In this sense, wound microenvironment is the core niche driving S. aureus evolution in vivo, where multi-compartmental pressures uncover its full spectrum of metabolic and virulence adaptations. Chang et al. highlighted SaeRS and other regulators as pivotal for intracellular survival in epithelial cells, a finding directly relevant for wound healing. Cells central to healing, such as keratinocytes, fibroblasts, and the blood-borne immune cells, may themselves be hijacked as intracellular sanctuaries (Fig. 1). Paradoxically, select bacterial metabolites can also accelerate re-epithelialization, compromising barrier quality to dampen epithelial antimicrobial-peptide (AMP) induction¹⁸. But could the stubborn delays in re-epithelialization characteristic of chronic diabetic wounds be driven, at least in part, by S. aureus persisting within keratinocytes or macrophages? Could invasion in fibroblasts compromise matrix remodeling and angiogenesis? Do wound-derived S. aureus isolates depend on the same intracellular gene sets identified by Chang et al.? These are not rhetorical questions but experimental imperatives. The answers could fundamentally reshape how we think about wound chronicity, moving it from a problem of impaired healing to one of microbial occupations at the cellular core.

Fig. 1. Wound as the crucible of S. aureus adaptive fitness.

Schematic representation of the wound microenvironment as a selective arena where S. aureus deploys its adaptive repertoire. The ischemic wound bed (bluish) reflects hypoxia, acidosis, and nutrient restriction. Polymicrobial competition within wound exudates affects nutrient availability and imposes selective pressures that influence S. aureus survival and adaptation. S. aureus occupies an intracellular niche within keratinocytes, fibroblasts, and immune cells, where it is shielded from antibiotics and immune clearance. Adaptation to nutrient limitation and oxidative stress is mediated by regulators such as SaeRS, enabling persistence and reseeding of chronic wounds. Blood vessels and infiltrating immune cells provide dynamic selective pressures, while host comorbidities such as diabetes, obesity, and immunosuppression further modify the fitness landscape. Within this crucible, S. aureus relies on a core set of survival genes and niche-specific programs to persist. Together, these overlapping constraints transform wounds into a central stage for bacterial adaptation, unveiling conserved and context-dependent vulnerabilities that may be exploited therapeutically. Created with BioRender.com (Created in BioRender. Ghatak, S. (2025) https://BioRender.com/nskagnq).

Lessons from the core survival set

The identification of 27 essential survival genes in S. aureus across three host microenvironments underscores conserved fitness mechanisms and warrants further investigation into their functional roles. Energy production and ion homeostasis, orchestrated by the atp operon and mnh antiporters, emerge as the irreducible lifelines of S. aureus. This matters in diabetes because metabolic dysregulation amplifies virulence, persistence, and evolvability. Excess glucose drives Agr-dependent toxin production¹⁹, while hyperglycemia triples aureolysin expression during skin infection, thereby worsening the disease outcome²⁰. Persistence is likewise potentiated. In diabetic mice, S. aureus burdens rise in catheter infections, an effect that is strictly glycolysis-dependent, as a ΔpfkA mutant cannot exploit hyperglycemia²¹. Extending this, S. aureus in diabetic hosts acquires antibiotic resistance faster than in non-diabetic controls²². Taken together, these data suggest that targeting universal fitness pathways could cut across virulence programs and persistence mechanisms, offering a path to overcome the ecological complexity that makes chronic wounds one of the most resilient strongholds of S. aureus. Against this backdrop, urgent and provocative questions arise for wound biologists.

• Do these same genes remain essential in the diabetic wound microenvironment, where glucose is abundant yet inefficiently metabolized, hypoxia undermines oxidative phosphorylation, and ischemia throttles nutrient diffusion?

• Could diabetes-induced epigenetic modifications enhance bacterial fitness in such niche?

• Could the metabolic flexibility that allows S. aureus to toggle between glucose and lactate in the bloodstream also be the very mechanism that equips it to flourish in hyperglycemic, lactate-rich wound exudates?

• Could disrupting these core metabolic circuits, weaken S. aureus fitness across the wound’s diverse compartments simultaneously?

• How do interspecies interactions modulate the requirement for the 27 core genes?

• Do cooperative or competitive dynamics in wound biofilms make some S. aureus survival pathways dispensable, while amplifying the importance of others?

• Could metabolic cross-feeding between pathogens alter the pathogen’s dependence on ATP synthase or ion transporters?

These questions point to a central therapeutic opportunity of targeting universal fitness pathways to overcome the ecological complexity of chronic wounds.

A call for wound-focused Tn-seq

The most disruptive insight from Chang et al.’s work is not only biological but methodological. Tn-seq has already proven its capacity to reveal essential survival pathways in epithelial cells, blood, macrophages, and systemic infection models¹⁷. In wound studies, co-infection has been shown to significantly impact S. aureus fitness, highlighting the translational potential of this approach^14,16,17. The next logical step is to extend these ex vivo wound fluid systems to in vivo chronic wound models that capture the fine-tuning of host pressures such as hyperglycemia, hypoxia, acidic pH, epigenetic modifications, and inflammation. Comparative studies across acute, diabetic, and ischemic wounds could illuminate environment-specific vulnerabilities. Such contrasts may reveal environment-specific vulnerabilities that explain why some wounds heal while others persist. By embedding Tn-seq within wound-relevant contexts, we can move beyond static descriptions of S. aureus persistence and instead construct a clinically actionable roadmap^14,16,17. In this vision, the genetics of bacterial fitness in wounds becomes not merely an academic exercise but the cornerstone of therapeutic innovation, guiding interventions that exploit wound-specific weaknesses and harness host pressures to control infection.

Rethinking bacterial adaptability beyond virulence

Looking ahead, advancing the field requires moving beyond a single lineage like USA300 and embracing the global diversity of S. aureus. More human-relevant and longitudinal models are essential to capture how host environments reshape bacterial fitness. Integrating multi-spatial host–pathogen omics will reveal how immune pressures and bacterial adaptations co-evolve. Chang et al. identified both universal and niche-specific fitness requirements of S. aureus, highlighting broad-spectrum targets and environment-specific vulnerabilities^3,23. This shift lays the groundwork for personalized infection management and explains why effective future vaccines require multivalent designs that account for the pathogen’s plasticity and host-dependent immune variation^3,5.

Unanswered questions at the wound-edge and future directions

Chang et al. redefined S. aureus pathogenesis as context-dependent rather than driven by a fixed virulence arsenal⁸. For wound biologists and infection researchers, this raises a set of urgent, unresolved questions:

• Are chronic wounds accelerators of microbial evolution?

• Do hyperglycemia, ischemia, and polymicrobial colonization merely permit persistence, or do they actively accelerate S. aureus virulence and resistance development?

• How directly intracellular infection sabotage re-epithelialization, matrix remodeling, and angiogenesis?

• Can conserved metabolic lifelines be therapeutically collapsed?

• Does targeting ATP generation and ion homeostasis offer a universal strategy across S. aureus infections, or will the bacterium’s evolutionary plasticity always outpace such interventions?

• Are static “snapshots” of fitness requirements sufficient, or do we need longitudinal, real-time monitoring of bacterial evolution within host tissues?

• How can we capture the temporal choreography of adaptation?

• To what extent do conditions such as diabetes, obesity, and immunosuppression reshape bacterial fitness in ways that can be therapeutically exploited?

• Do comorbidities create predictable vulnerabilities?

• Could direct fitness profiling of wound isolates without laboratory passaging reveal niche-restricted vulnerabilities invisible in systemic models?

• Can multi-spatial-omics redefine therapy design?

• How might integrated host–pathogen mapping across spatial and metabolic scales transforms our ability to design personalized infection therapies?

• Should antimicrobial development pivot from neutralizing specific determinants to disrupting the capacity for ecological versatility itself?

Together, these questions shift the field’s center of gravity, from cataloging virulence to interrogating adaptability, from describing persistence to dismantling it. Chronic wounds, in this light, are not marginal complications but environments in which S. aureus adaptability reaches its fullest expression, where the next generation of therapeutic strategies must emerge.

From insight to intervention

Chang et al.’s work has shown us that the resilience of S. aureus is in its extraordinary ecological versatility^3,8. They provide a conceptual roadmap for therapeutic innovation by exposing both niche-specific adaptive programs and conserved metabolic lifelines⁸. For wound biologists, these findings resonate with urgent clinical realities. If we can identify which of the 27 core survival genes remain indispensable in hyperglycemic, immune-dysfunctional, and ischemic tissues and how niche-specific requirements shift, we may finally develop strategies that collapse S. aureus fitness across all wound compartments. From this vantage, a new set of questions emerges to guide the next decade of infection biology and wound therapeutics.

Author contributions

S.G. and F.M.O. contributed to the conceptualization, writing, and editing of the manuscript. S.G. supervised and acquired the funding.

Peer review

Peer review information

Nature Communications thanks Arthur Tarricone, and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. A peer review file is available.

Competing interests

The authors declare no competing interests.